Singaporean extradited to US over alleged global insider trading network
A SINGAPOREAN man accused of helping lead a global insider trading network that allegedly generated tens of millions of dollars in illicit profits has been extradited to the United States to face securities fraud and money laundering charges. Zhi Ge,...
Singaporean citizen Zhi Ge, 35, faces extradition to the United States to stand trial on securities fraud and money laundering charges. These allegations stem from a global insider trading network, according to prosecutors, which allegedly amassed tens of millions of dollars through the use of confidential corporate information.
Ge appeared in federal court in Boston on Friday following his extradition from Singapore, where he was arrested in 2024. The indictment, filed by US prosecutors, details a scheme that allegedly operated between 2016 and 2024, involving the recruitment of investment bankers and other insiders through the provision of confidential information in exchange for privileged trading tips.
The charges against Ge are centered on his alleged role as the leader of this scheme, which reportedly targeted major corporate mergers and acquisitions, including the US$39 billion acquisition of Alexion Pharmaceuticals by AstraZeneca and the US$2.9 billion acquisition of MorphoSys by Novartis. Prosecutors allege that Ge sought to expand his network, sending messages in 2019 to an actor friend in New York requesting assistance in recruiting additional insiders.
The scheme is said to have employed covert communication methods, such as disposable mobile phones, encrypted messaging applications, and coded language, to obfuscate its activities. To further conceal their actions, the defendants reportedly referred to money as "greens" and potential merger partners as "girls" and "models." Ge's legal team plans to contest the charges, with his lawyer, Kevin Barron, stating that Ge will plead not guilty.
Written by urgent.news from The Vibes's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.